Stock Price Quote

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE2802.20-46.2 (-1.62 %)
PREV CLOSE ( ) 2848.40
OPEN PRICE ( ) 2843.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1372
TODAY'S LOW / HIGH ( )2794.00 2882.10
52 WK LOW / HIGH ( )1635.3 2940.45
NSE2813.70-33.85 (-1.19 %)
PREV CLOSE( ) 2847.55
OPEN PRICE ( ) 2847.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2813.70 (109)
VOLUME 13087
TODAY'S LOW / HIGH( ) 2801.00 2892.00
52 WK LOW / HIGH ( )1632.55 2939.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX

NEWS

02Jan Astrazeneca Pharma India informs about
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, Astrazene..
11Nov AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that at the Board meeting of the C..
26Sep AstraZeneca Pharma secures import, mar
AstraZeneca Pharma India has received import and market permission in Fo..
22Jul Astrazeneca Pharma India informs about
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disc..
03Apr AstraZeneca Pharma hosts ‘Wellness by
AstraZeneca Pharma India (AZPIL) has hosted an engaging awareness progra..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit267.01544.41
Gross Profit 351.82 726.64
Operating Profit 402.24875.88
Net Sales 2238.637282.94

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7322.90 (2.05%)
M.Cap ( in Cr)16865.09
Ajanta Pharma (BSE)
peergroup  1446.05 (10.03%)
M.Cap ( in Cr)12618.42
Ipca Laboratories (BSE)
peergroup  1456.15 (3.43%)
M.Cap ( in Cr)18398.76
Solara Active Pharma (BSE)
peergroup  680.25 (6.01%)
M.Cap ( in Cr)1772.41
Alkem Laboratories (BSE)
peergroup  2657.75 (1.39%)
M.Cap ( in Cr)31777.39

Shareholding Pattern

PROMOTERS 75%
MUTUAL FUNDS/UTI 3.35%
NON-INSTITUTION 19.24%
FI/BANKS/INSURANCE 0.06%
GOVERNMENT 0%
FII 0%

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd. was incorporated in the year 1979. Its today's share price is 2802.2. Its current market capitalisation stands at Rs 7005.5 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7282.9 Cr and Total Income of Rs.7445.8 Cr. The company's management includes Rajesh Marwaha, Gagandeep Singh Bedi, Weiying Sarah Wang, Ian John Parish, Kimsuka Narsimhan, Revathy Ashok, Narayan K Seshadri.

It is listed on the BSE with a BSE Code of 506820 , NSE with an NSE Symbol of ASTRAZEN and ISIN of INE203A01020. It's Registered office is at Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring RoadBengaluru-560045, Karnataka. Their Registrars are ACC Ltd. It's auditors are AF Ferguson & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X